ARCHIVES

SWOG Closes Prostate Cancer Trial With Mitoxantrone

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

NCAB Says President’s Budget Would “Seriously Damage” Cancer Program

February 12, 1999

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December 12, 2003